Effect of epidural anesthesia on the quality of short-term rehabilitation in hospital after surgery for cancer

ISRCTN ISRCTN16446449
DOI https://doi.org/10.1186/ISRCTN16446449
Submission date
09/10/2021
Registration date
26/10/2021
Last edited
26/10/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Patients with cancer are often accompanied by a variety of diseases and internal milieu disturbance, surgical resection is still confronted by many issues. Thoracic epidural anesthesia (TEA) (an injection in your back to stop you feeling pain in part of your body) and postoperative analgesia (pain medication) are often used in surgery to remove cancer. However, there are also some problems with the practical application of TEA, especially the difficulty of puncture and catheter detachment and displacement, which constitute the main factors affecting epidural analgesia that greatly compromise the patient’s satisfaction.

The aim of this study is to perform a retrospective study on the postoperative short-term rehabilitation quality of patients with cancer undergoing minimally invasive radical resection based on the TEA combined with general anesthesia in comparison with general anesthesia alone.

Who can participate?
Patients aged 18 to 80 years undergoing minimally invasive surgery for cancer under general anesthesia.

What does the study involve?
Patients undergoing minimally invasive surgery with cancer under general anesthesia were selected sequentially from our database. According to whether TEA was used in anesthesia, the patients were divided into two groups, namely the TEA group and the control group (general anesthesia alone). The general anesthesia regimen was identical for both groups. In the TEA group, ropivacaine was given before general anesthesia, and the same dose of medicament was supplied at an intraoperative interval of 2h to maintain the block level. The epidural catheter was removed after surgery. Both groups were subjected to patient-controlled intravenous analgesia (PCIA). We will analyze the patient's conditions during and after surgery.

What are the possible benefits and risks of participating?
The application of TEA in minimally invasive radical resection of cancer can significantly reduce the dosages of intraoperative anesthetic drugs and postoperative opioid drugs, which is beneficial to the postoperative recovery of patients.

Where is the study run from?
General Hospital of Southern Theatre Command of PLA (China)

When is the study starting and how long is it expected to run for?
February 2021 to December 2021

Who is funding the study?
Natural Science Foundation of Guangdong Province (China)

Who is the main contact?
Zhaoju Li, hellenanna@126.com

Contact information

Mrs Zhaoju Li
Public

Department of Anesthesiology
General Hospital of Southern Theatre Command of PLA
111 Liuhua Road
Yuexiu District
Guangzhou
510000
China

Phone +86 15602405803
Email wftuyx02@163.com

Study information

Study designSingle-center retrospective cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not applicable (retrospective study)
Scientific titleA retrospective study on the postoperative short-term rehabilitation quality of patients with cancer undergoing minimally invasive radical resection based on thoracic epidural anesthesia (TEA) combined with general anesthesia in comparison with general anesthesia alone
Study objectivesThe application of TEA in minimally invasive radical resection of cancer can significantly reduce the dosages of intraoperative anesthetic drugs and postoperative opioid drugs, lower analgesia-related adverse reactions, which is beneficial to rehabilitation of patients after surgery.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedEffect of intraoperative thoracic epidural anesthesia on the quality of hospital short-term rehabilitation after minimally invasive radical resection of cancer
InterventionPatients undergoing minimally invasive surgery with cancer under general anesthesia according to whether TEA was used in anesthesia, the patients were divided into two groups, namely the TEA group and the control group (general anesthesia alone). The general anesthesia regimen was identical for both groups. In the TEA group, 0.15% ropivacaine (0.05 mL/kg) was given before general anesthesia, and the same dose of medicament was supplied at an intraoperative interval of 2 h to maintain the block level. The epidural catheter was removed after surgery. Both groups were subjected to patient-controlled intravenous analgesia (PCIA) using sufentanil (3 μg/kg), dexmedetomidine (2.5 μg/kg), and 2.5 mg of haloperidol in 150 mL of normal saline 30 min before the end of the surgery. The continuous basal dose was 1mL/h, and the single-dose was 2.5 mL.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Ropivacaine, sufentanil, dexmedetomidine, haloperidol
Primary outcome measureMeasured using patient records:
1. Dosage of anesthesia and vasoactive drugs used throughout the procedure
2. Postoperative analgesic information, including the time of the first pressing (i.e., the time when the surgery is over), the consumption of analgesic drugs, and the resting and motorial analgesic scores (R-VAS and M-VAS) at 24, 48 and 72 h postoperatively
Secondary outcome measuresMeasured using patient records:
1. Demographic information: sex, age, height and weight, smoking and drinking history, preoperative complication of cardiovascular disease, diabetes mellitus, before the operation
2. Duration of the operation (min)
Overall study start date01/02/2021
Completion date01/12/2021

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants100
Total final enrolment100
Key inclusion criteriaPatients aged 18 - 80 years undergoing minimally invasive surgery with cancer under general anesthesia
Key exclusion criteria1. Patients with abnormal blood coagulation indices through the laboratory examination 48 h before operation
2. Patients with the operation time exceeding 12 h
3. Patients with operative method changed to thoracotomy or laparotomy
4. Patients with exploratory thoracotomy or laparotomy within 48 h after the operation
Date of first enrolment01/01/2018
Date of final enrolment01/01/2021

Locations

Countries of recruitment

  • China

Study participating centre

The Southern Theater General Hospital of the Chinese People's Liberation Army
Department of Anesthesiology
General Hospital of Southern Theatre Command of PLA
111 Liuhua Road
Yuexiu District
Guangzhou
510000
China

Sponsor information

General Hospital of Southern Theatre Command of PLA
Hospital/treatment centre

111 Liuhua Road
Yuexiu District
Guangzhou
510000
China

Phone +86 15602405803
Email hellenanna@126.com

Funders

Funder type

Government

Natural Science Foundation of Guangdong Province
Government organisation / Local government
Alternative name(s)
Guangdong Provincial Natural Science Foundation, Natural Science Foundation of Guangdong, Guangdong Natural Science Foundation, Natural Science Fund of Guangdong Province, 廣東省自然科學基金
Location
China

Results and Publications

Intention to publish date31/12/2022
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryOther
Publication and dissemination planA study is planned for publication in a medical journal.
IPD sharing planAll data generated or analysed during this study will be included in the subsequent results publication.

Editorial Notes

21/10/2021: Trial's existence confirmed by Natural Science Foundation of Guangdong Province.